January 18, 2012 — Boston Scientific reported nine-month clinical endpoint data from its ORION trial, demonstrating ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.
January 13, 2012 — Amorcyte Inc.,a NeoStem Inc. company, announced the expansion of intellectual property protection ...
December 22, 2011 – Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...
December 13, 2011 – Boston Scientific announced the U.S. launch of its Charger PTA Balloon Catheter, a 0.035-inch ...
November 23, 2011 – Vascular occlusions are blocked blood vessels caused by a blood clot in an artery. Blocks in the ...
November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post ...
November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...
November 4, 2011 — Medtronic Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant ...
November 1, 2011 – Boston Scientific released the schedule of its major events and product-related clinical research for ...
October 17, 2011 — The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has become the first cardiac care ...
October 14, 2011 – A U.S. Food and Drug Administration (FDA) review panel gave its unanimous recommendation for the ...
October 3, 2011 – Maquet Cardiovascular has signed a definitive agreement to acquire Atrium Medical Corp. for $680 ...
September 30, 2011 — The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) ...
There have been several key news items from the U.S. stent market over the past year. These include the introduction of ...
September 20, 2011 — Boston Scientific Corp. has launched its Coyote Balloon Catheter, a highly deliverable and ultra ...
January 18, 2012